Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis

Authors: Joanna Crichton, Matthew Hickman, Rona Campbell, Harriet Batista-Ferrer, John Macleod

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

The success of chlamydia screening programmes relies on their ability to effectively target those with greatest need. Young people from disadvantaged backgrounds may be at greater need for chlamydia screening, but existing evidence on the variation of prevalence with social position is inconclusive. We carried out a systematic review to examine variation in chlamydia prevalence in populations and possible sources of this variation.

Methods

Studies were eligible if they reported chlamydia prevalence derived from population-based samples that included young people aged 15–24 years from Europe, North America or Australia. Systematic searches of the following databases were undertaken from their inception to November 2014: MEDLINE, Embase, Web of Science and PsychINFO. There were no restrictions by language or publication date. Independent screening for eligibility and data extraction were carried out by two reviewers. Where possible, data were pooled in a meta-analysis using a random effects model. Heterogeneity was further investigated using meta-regression techniques.

Results

Of 1248 unique titles and abstracts and 263 potentially relevant full texts, 29 studies were eligible for inclusion. There was relatively strong evidence that disadvantaged young people had an increased risk of having a chlamydia infection across multiple measures of disadvantage, including lower educational attainment (OR 1.94, 95 % CI: 1.52 to 2.47), lower occupational class (OR 1.49, 95 % CI: 1.07 to 2.08) and residence in deprived areas (OR 1.76, 95 % CI: 1.15 to 2.71) with an overall OR of 1.66 (95 % CI: 1.37 to 2.02). Socioeconomic disadvantage was associated with chlamydia infection in both men and women. There was weaker evidence that prevalence estimates also varied by gender and age.

Conclusions

This review provides evidence of a consistent association between socioeconomic disadvantage and higher risk of Chlamydia infection. This association may reflect a number of factors including social variation in engagement with Chlamydia control programmes. Chlamydia screening could therefore reduce or increase health inequalities, depending on service provision and uptake by different socioeconomic groups.
Appendix
Available only for authorised users
Literature
1.
Turner KME, Adams EJ, LaMontagne DS, Emmett L, Baster K, Edmunds WJ. Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect. 2006;82(6):496–502.CrossRefPubMedPubMedCentral
2.
3.
Evenden D, Harper PR, Brailsford SC, Harindra V. Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies. J Oper Res Soc. 2006;57(12):1400–12.CrossRef
4.
Stein CR, Kaufman JS, Ford CA, Leone PA, Feldblum PJ, Miller WC. Screening Young Adults for Prevalent Chlamydial Infection in Community Settings. Ann Epidemiol. 2008;18(7):560–71.CrossRefPubMedPubMedCentral
5.
Gotz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect. 2005;81(1):24–30.CrossRefPubMedPubMedCentral
6.
Gotz HM, Veldhuijzen IK, Habbema JDF, Boeke AJP, Richardus JH, Steyerberg EW. Prediction of Chlamydia trachomatis infection: Application of a scoring rule to other populations. Sex Transm Dis. 2006;33(6):374–80.CrossRefPubMed
7.
Kretzschmar M, Turner KM, Barton PM, Edmunds WJ, Low N. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect. 2009;85(5):359–66.CrossRefPubMed
8.
Simms I, Talebi A, Riha J, Horner P, French RS, Sarah R, et al. The English National Chlamydia Screening Programme: Variations in Positivity in 2007/2008. Sex Transm Dis. 2009;36(8):522–7.CrossRefPubMed
9.
10.
Sheringham J, Mann S, Simms I, Stafford M, Hart GJ, Raine R. It matters what you measure: a systematic literature review examining whether young people in poorer socioeconomic circumstances are more at risk of chlamydia. Sex Transm Infect. 2013;89(2):175–80.CrossRefPubMed
11.
Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687–91.CrossRefPubMed
12.
Imamura M, Tucker J, Hannaford P, da Silva MO, Astin M, Wyness L, et al. Factors associated with teenage pregnancy in the European Union countries: a systematic review. Eur J Pub Health. 2007;17(6):630–6.CrossRef
13.
Johnson SA, Simms I, Sheringham J, Bickler G, Bennett CM, Hall R, et al. The implementation of chlamydia screening: a cross-sectional study in the south east of England. Sex Transm Infect. 2010;86(3):217–21.CrossRefPubMed
14.
National Chlamydia Screening Programme: The Bigger Picture The National Chlamydia Screening Programme 2008/09 Annual Report. In. London; 2009.
15.
Adams EJ, Charlett A, Edmunds WJ, Hughes G. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect. 2004;80(5):354–62.CrossRefPubMedPubMedCentral
16.
Vajdic CM, Middleton M, Bowden FJ, Fairley CK, Kaldor JM. The prevalence of genital Chlamydia trachomatis in Australia 1997–2004: a systematic review. Sex Health. 2005;2(3):169–83.CrossRefPubMed
17.
Wilson JS, Honey E, Templeton A, Paavonen J, Mardh PA, Stray-Pedersen B, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002;8(4):385–94.CrossRefPubMed
18.
Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2009;38(2):435–48.CrossRefPubMed
19.
Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22(1):128. author reply 128.CrossRefPubMed
20.
21.
22.
Higgins JP. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–60.CrossRefPubMed
23.
Hocking JS, Walker J, Regan D, Chen MY, Fairley CK. Chlamydia screening--Australia should strive to achieve what others have not. Med J Aust. 2008;188(2):106–8.PubMed
24.
Low N, Cassell JA, Spencer B, Bender N, Hilber AM, van Bergen J, et al. Chlamydia control activities in Europe: cross-sectional survey. Eur J Public Health. 2012;22(4):556–61.CrossRefPubMed
25.
Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J, et al. Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect. 2010;86(4):263–70.CrossRefPubMed
26.
van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Deville W, Bouter LM, et al. Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population. Sex Transm Infect. 2000;76(5):375–80.CrossRefPubMedPubMedCentral
27.
Vuylsteke B, Vandenbruaene M, Vandenbulcke P, Van Dyck E, Laga M. Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm Infect. 1999;75(3):152–5.CrossRefPubMedPubMedCentral
28.
Van Bergen J, Gotz HM, Richardus JH, Hoebe CJPA, Broer J, Coenen AJT. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: Results from the first national population based study in the Netherlands. Sex Transm Infect. 2005;81(1):17–23.CrossRefPubMedPubMedCentral
29.
Klovstad H, Grjibovski A, Aavitsland P. Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: a cross sectional study. BMC Infect Dis. 2012;12:150.CrossRefPubMedPubMedCentral
30.
Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, et al. Chlamydia trachomatis trends in the united states among persons 14 to 39 Years of Age, 1999–2008. Sex Transm Dis. 2012;39(2):92–6.CrossRefPubMed
31.
Eggleston E, Rogers SM, Turner CF, Miller WC, Roman AM, Hobbs MM, et al. Chlamydia trachomatis Infection Among 15-to 35-Year-Olds in Baltimore, MD. Sex Transm Dis. 2011;38(8):743–9.PubMedPubMedCentral
32.
Crichton J, Hickman M, Campbell R, Heron J, Horner P, Macleod J. Prevalence of chlamydia in young adulthood and association with life course socioeconomic position: birth cohort study. PLoS One. 2014;9(8):e104943.CrossRefPubMedPubMedCentral
33.
Gravningen K, Furberg AS, Simonsen GS, Wilsgaard T. Early sexual behaviour and Chlamydia trachomatis infection - a population based cross-sectional study on gender differences among adolescents in Norway. BMC Infect Dis. 2012;12:319.CrossRefPubMedPubMedCentral
34.
Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection.[Erratum appears in Lancet 2002 Jan 12;359(9301):174]. Lancet. 2001;358(9296):1851–4.CrossRefPubMed
35.
Bozicevic I, Grgic I, Zidovec-Lepej S, Cakalo JI, Belak-Kovacevic S, Stulhofer A, et al. Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: feasibility and prevalence. BMC Public Health. 2011;11:230.CrossRefPubMedPubMedCentral
36.
Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assessment (Winchester, England). 2007;11(8):iii–iv. ix-xii, 1–165.
37.
Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795–806.CrossRefPubMedPubMedCentral
38.
Haar K, Bremer V, Houareau C, Meyer T, Desai S, Thamm M, et al. Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003–2006. Eurosurveillance. 2013;18(34):18–27.CrossRef
39.
Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, et al. Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002. Ann Intern Med. 2007;147(2):89–96.CrossRefPubMed
40.
Andersen B, Olesen F, Moller JK, Ostergaard L. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J Infect Dis. 2002;185(2):252–8.CrossRefPubMed
41.
Ostergaard L, Andersen B, Olesen F, Moller JK. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. BMJ. 1998;317(7150):26–7.CrossRefPubMedPubMedCentral
42.
Munk C, Morre SA, Kjaer SK, Poll PA, Bock JE, Meijer CJ, et al. PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants. Sex Transm Dis. 1999;26(6):325–8.CrossRefPubMed
43.
van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, Hoebe CJ, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ. 2012;345:e4316.CrossRefPubMedPubMedCentral
44.
Franceschi S, Smith JS, Van Den Brule A, Herrero R, Arslan A, Anh PTH, et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents: A cross-sectional study. Sex Transm Dis. 2007;34(8):563–9.PubMed
45.
Fernandez-Benitez C, Mejuto-Lopez P, Otero-Guerra L, Margolles-Martins MJ, Suarez-Leiva P, Vazquez F. Chlamydial Primary Care G: Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain. BMC Infect Dis. 2013;13:388.CrossRefPubMedPubMedCentral
46.
Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;291(18):2229–36.CrossRefPubMed
47.
Uuskula A, Kals M, Denks K, Nurm UK, Kasesalu L, DeHovitz J, et al. The prevalence of chlamydial infection in Estonia: A population-based survey. Int J STD AIDS. 2008;19(7):455–8.CrossRefPubMedPubMedCentral
48.
Ku L, St Louis M, Farshy C, Aral S, Turner CF, Lindberg LD, et al. Risk behaviors, medical care, and chlamydial infection among young men in the United States. Am J Public Health. 2002;92(7):1140–3.CrossRefPubMedPubMedCentral
49.
Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination, University of York; 2008.
50.
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21(11):1559–73.CrossRefPubMed
51.
Riha J, Mercer CH, Soldan K, French CE, Macintosh M. Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data. Sex Transm Infect. 2011;87(4):306–11.CrossRefPubMedPubMedCentral
52.
Radcliffe KW, Ahmad S, Gilleran G, Ross JD. Demographic and behavioural profile of adults infected with chlamydia: a case–control study. Sex Transm Infect. 2001;77(4):265–70.CrossRefPubMedPubMedCentral
53.
Low N, Sterne JAC, Barlow D. Inequalities in rates of gonorrhoea and chlamydia between black ethnic groups in south east London: cross sectional study. Sex Transm Infect. 2001;77(1):15–20.CrossRefPubMedPubMedCentral
54.
Van Bergen J, Gotz H, Richardus JH, Hoebe C, Broer J, Coenen T. Prevalence of urogenital Chlamydia trachomatis infections in the Netherlands suggests selective screening approaches. Results from the pilot CT population study. Drugs Today. 2006;42(Suppl A):25–33.
55.
Dielissen PW, Teunissen DAM, Lagro-Janssen ALM. Chlamydia prevalence in the general population: Is there a sex difference? A systematic review. BMC Infect Dis. 2013;13(1):534.CrossRefPubMedPubMedCentral
56.
Buffardi AL, Thomas KK, Holmes KK, Manhart LE. Moving upstream: ecosocial and psychosocial correlates of sexually transmitted infections among young adults in the United States. Am J Public Health. 2008;98(6):1128–36.CrossRefPubMedPubMedCentral
57.
Cubbin C, Santelli J, Brindis CD, Braveman P. Neighborhood context and sexual behaviors among adolescents: Findings from the National Longitudinal Study of Adolescent Health. Perspect Sex Reprod Health. 2005;37(3):125–34.CrossRefPubMed
58.
Santelli JS, Lowry R, Brener ND, Robin L. The association of sexual behaviors with socioeconomic status, family structure, and race/ethnicity among US adolescents. Am J Public Health. 2000;90(10):1582–8.CrossRefPubMedPubMedCentral
59.
Mercer CH, Copas AJ, Sonnenberg P, Johnson AM, McManus S, Erens B, et al. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. Int J Epidemiol. 2009;38(1):206–14.CrossRefPubMed
60.
Sheringham J, Simms I, Riha J, Talebi A, Emmett L, Macintosh M, et al. Will Chlamydia Screening Reach Young People in Deprived Areas in England? Baseline Analysis of the English National Chlamydia Screening Programme Delivery in 2008. Sex Transm Dis. 2011;38(8):677–84.PubMed
61.
Horner P, Soldan K, Vieira SM, Wills GS, Woodhall SC, Pebody R, et al. C. trachomatis pgp3 Antibody Prevalence in Young Women in England, 1993–2010. PLoS One. 2013;8(8):e72001.CrossRefPubMedPubMedCentral
Metadata
Title
Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis
Authors
Joanna Crichton
Matthew Hickman
Rona Campbell
Harriet Batista-Ferrer
John Macleod
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-2069-7

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates – a cross-sectional study

Research article

Perceptions and acceptability of pictorial health warning labels vs text only - a cross-sectional study in Lao PDR

Research article

Individual and community level determinants of childhood full immunization in Ethiopia: a multilevel analysis

Research article

Self-reported sitting time and physical activity: interactive associations with mental well-being and productivity in office employees

Research article

The effectiveness of community engagement in public health interventions for disadvantaged groups: a meta-analysis

Research article

Low back pain and physical activity – A 6.5 year follow-up among young adults in their transition from school to working life